UPDATE: Morgan Stanley Reiterates On Amgen Following AMAGINE-1 Study By: Benzinga via Benzinga May 12, 2014 at 09:21 AM EDT In a report published Monday, Morgan Stanley analyst Matthew Harrison reiterated an Overweight rating on Amgen (NASDAQ: AMGN), but ... Read More >> Related Stocks: Amgen